Skip to content
sellWeak

Kck Ltd. sold $303k of NPCE

owner at NeuroPace Inc. 46,426 shares at an average of $6.53, traded Oct 3, 2024, filed Oct 18, 2024.

Warning score
26
Value
$303k
46,426 shares
Holdings after
5,507,663
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $303k at market
    +14
  • Share of holdings sold
    Sold 0.8% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +38.8%, 3m +85.0%, 6m +66.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

NPCEOct 12, 2026 · close 13.00
Since filing Oct 18, 2024: +100.9%SPY +36.2% · excess +64.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001657662-24-000004, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Oct 3, 2024SOpen-market sale
Common Stock
-3,318$6.97$23k5,550,771Oct 18, 2024
Oct 4, 2024SOpen-market sale
Common Stock
-5,757$6.92$40k5,545,014Oct 18, 2024
Oct 7, 2024SOpen-market sale
Common Stock
-4,910$6.66$33k5,540,104Oct 18, 2024
Oct 8, 2024SOpen-market sale
Common Stock
-6,000$6.43$39k5,534,104Oct 18, 2024
Oct 9, 2024SOpen-market sale
Common Stock
-3,123$6.10$19k5,530,981Oct 18, 2024
Oct 10, 2024SOpen-market sale
Common Stock
-2,504$6.12$15k5,528,477Oct 18, 2024
Oct 11, 2024SOpen-market sale
Common Stock
-2,572$6.35$16k5,525,905Oct 18, 2024
Oct 14, 2024SOpen-market sale
Common Stock
-4,031$6.54$26k5,521,874Oct 18, 2024
Oct 15, 2024SOpen-market sale
Common Stock
-4,017$6.50$26k5,517,857Oct 18, 2024
Oct 16, 2024SOpen-market sale
Common Stock
-6,900$6.57$45k5,510,957Oct 18, 2024
Oct 17, 2024SOpen-market sale
Common Stock
-3,294$6.28$21k5,507,663Oct 18, 2024

Related signals

Other insiders at NeuroPace Inc and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
NPCEsell10b5-1
NeuroPace Inc
Martha Morrell
CHIEF MEDICAL OFFICER
$399k
25,000 shares
-33%
37Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$2.7M
168,136 shares
-5%
57Moderate
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$50M
5,270,845 shares
-100%
37Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$1.2M
224,138 shares
-4%
12Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$25k
4,082 shares
-0%
19Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$53k
8,598 shares
-0%
25Weak
NPCEsell
NeuroPace Inc
Kck Ltd.
owner
$275k
39,684 shares
-1%
28Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$409k
29,206 shares
-1%
17Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$25k
1,781 shares
-0%
36Weak
NPCEsell
NeuroPace Inc
Orbimed Advisors LLC
owner
$913k
64,653 shares
-2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kck Ltd. sold $303k of NPCE | InsiderTell